Reducing nightmares in adults with narcolepsy
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new behavioral treatment to reduce nightmares in adults with narcolepsy. It aims to help you sleep better and feel more rested.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with narcolepsy (type 1 or type 2).
- You have nightmares at least once a week.
- You are 18 or older, live in the United States, and speak English.
- Your sleep and psychiatric medications have been stable for at least a month, and you can keep them stable during the study.
- You are not currently in trauma therapy or sleep therapy, and you haven't had behavioral treatment for nightmares before.
- If you have sleep apnea, it must be treated (not untreated moderate or severe sleep apnea).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a behavioral therapy (non-drug treatment) for nightmares in people with REM sleep behavior disorder (RBD). It's designed for you and a family member who lives with you.
This study is testing a new approach to help military members and veterans who have trouble sleeping, including nightmares or a racing heart at night. It may be a good fit if you have insomnia and are not currently taking sleep medications.
This study tests two non-drug treatments for nightmares and sleep problems in active-duty service members and veterans. You would either get a therapy that helps you change nightmare content or try a special wristband that monitors your sleep and can gently vibrate to reduce nightmares.
This study looks at how people with type 1 narcolepsy understand their own and others' thoughts and feelings (called mentalizing). It compares them to people with treated sleep apnea to see if there are differences.
This study tests a new medication called TAK-360 to help adults with narcolepsy type 1 (a condition that causes extreme daytime sleepiness and sudden muscle weakness called cataplexy) feel more alert during the day. The goal is to see if this treatment is safe and effective for managing narcolepsy symptoms.
This study tests a new medication, ALKS 2680, to see if it helps reduce daytime sleepiness and other symptoms in adults with narcolepsy type 1. It may offer a new treatment option for people with this condition.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.